Institut National de la Statistique, Ministère de l’Économie de la Planification et de l’Aménagement du Territoire, Ministère de la Santé Publique [Cameroon] and ICF International., Minnesota Population Center
431) Were you given SP/Fansidar/ Maloxine during a prenatal visit, during another visit to a health facility, or in another place?
[ASK FOR MOST RECENT BIRTH ONLY]
PRENATAL VISIT 1
OTHER MEDICAL VISIT 2
OTHER SOURCE 6
Categories
Value
Category
1
Antenatal visit
2
Another facility visit
3
Other source
8
Missing
9
NIU (not in universe)
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Description
Definition
For children born in the five years before the survey to women who received antenatal care and took SP/Fansidar while the child was in utero, ANMALSPSRC (ML2) indicates whether the SP/Fansidar came from an antenatal care visit, another visit to a health facility, or from some other source. This drug is used to treat malaria.